From: Evaluation of antinociceptive, in-vivo & in-vitro anti-inflammatory activity of ethanolic extract of Curcuma zedoaria rhizome
Early phase (0–5 min)
Late phase (20–30 min)
Treatment
% inhibition
Standard
67.97
75.25
Drug 250Â mg
64.04
58.42
Drug 500Â mg
64.49
62.37